AKR1C1 and SRD5A1 Messenger RNA Expression at Term in the Human Myometrium and Chorioamniotic Membranes

 

 Buy Article Permissions and Reprints

ABSTRACT

We sought to determine relative mRNA expression of AKR1C1 and SRD5A1, which respectively encode for the key progesterone metabolizing enzymes, 20α-hydroxysteroid dehydrogenase and 5α-reductase type 1, in the myometrium and chorioamniotic membranes during human spontaneous or induced labor and nonlabor. Quantitative real-time reverse-transcriptase polymerase chain reaction was used to compare relative mRNA expression of AKR1C1 and SRD5A1 in the myometrium and chorioamniotic membranes from 20 subjects during three different states of labor: not in labor (n = 10), spontaneous labor (n = 5), or induced labor (n = 5). Labor was defined as regular uterine contractions that resulted in cervical dilation. Myometrial AKR1C1 mRNA expression was significantly greater in spontaneously laboring subjects compared with those not in labor (2.4-fold [1.97 to 2.98], p = 0.02). There was no difference in myometrial AKR1C1 mRNA expression between those with induced labor compared with those not in labor. Regardless of labor status, no differences were observed in the chorioamniotic membrane AKR1C1 mRNA expression between the groups. SRD5A1 mRNA expression was significantly lower in the membranes of both laboring groups when compared with those not in labor (spontaneous: 0.10-fold [0.06 to 0.18], p = 0.007; induced: 0.09-fold [0.03 to 0.25], p = 0.013). Regardless of labor status, there was no difference in SRD5A1 mRNA expression in the myometrium. Our study demonstrated tissue-specific changes in progesterone metabolizing enzyme mRNA expression in human intrauterine tissue at term associated with labor status. These observed changes in mRNA expression may have important implications for progesterone metabolism at those specific sites and thereby may differentially regulate the tissue-specific progesterone concentration and/or the level of specific progesterone metabolites.

REFERENCES

• 1 Csapo A I, Knobil E, van der Molen H J, Wiest W G. Peripheral plasma progesterone levels during human pregnancy and labor.  Am J Obstet Gynecol. 1971;  110 630-632
  PubMedGoogle Scholar
• 2 Turnbull A C, Patten P T, Flint A P, Keirse M J, Jeremy J Y, Anderson A B. Significant fall in progesterone and rise in oestradiol levels in human peripheral plasma before onset of labour.  Lancet. 1974;  1 101-103
  PubMedGoogle Scholar
• 3 Meis P J, Klebanoff M, Thom E et al.. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.  N Engl J Med. 2003;  348 2379-2385
  CrossrefPubMedGoogle Scholar
• 4 da Fonseca E B, Bittar R E, Carvalho M H, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study.  Am J Obstet Gynecol. 2003;  188 419-424
  CrossrefPubMedGoogle Scholar
• 5 Frydman R, Lelaidier C, Baton-Saint-Mleux C, Fernandez H, Vial M, Bourget P. Labor induction in women at term with mifepristone (RU 486): a double-blind, randomized, placebo-controlled study.  Obstet Gynecol. 1992;  80 972-975
  PubMedGoogle Scholar
• 6 Mesiano S. Myometrial progesterone responsiveness and the control of human parturition.  J Soc Gynecol Investig. 2004;  11 193-202
  CrossrefPubMedGoogle Scholar
• 7 Piekorz R P, Gingras S, Hoffmeyer A, Ihle J N, Weinstein Y. Regulation of progesterone levels during pregnancy and parturition by signal transducer and activator of transcription 5 and 20alpha-hydroxysteroid dehydrogenase.  Mol Endocrinol. 2005;  19 431-440
  PubMedGoogle Scholar
• 8 Sheehan P M. A possible role for progesterone metabolites in human parturition.  Aust N Z J Obstet Gynaecol. 2006;  46 159-163
  CrossrefPubMedGoogle Scholar
• 9 Runnebaum B, Zander J. Progesterone and 20 alpha-dihydroprogesterone in human myometrium during pregnancy.  Acta Endocrinol Suppl (Copenh). 1971;  150 3-45
  PubMedGoogle Scholar
• 10 Milewich L, Gant N F, Schwarz B E, Chen G T, MacDonald P C. Initiation of human parturition. VIII. Metabolism of progesterone by fetal membranes of early and late human gestation.  Obstet Gynecol. 1977;  50 45-48
  PubMedGoogle Scholar
• 11 Mitchell B F, Wong S. Changes in 17 beta,20 alpha-hydroxysteroid dehydrogenase activity supporting an increase in the estrogen/progesterone ratio of human fetal membranes at parturition.  Am J Obstet Gynecol. 1993;  168 1377-1385
  PubMedGoogle Scholar
• 12 Mickan H. Saturated metabolites of progesterone in human myometrium during pregnancy.  Steroids. 1976;  27 65-77
  CrossrefPubMedGoogle Scholar
• 13 Junkermann H, Runnebaum B, Lisboa B P. New progesterone metabolites in human myometrium.  Steroids. 1977;  30 1-14
  CrossrefPubMedGoogle Scholar
• 14 Ji Q, Chang L, VanDenBerg D, Stanczyk F Z, Stolz A. Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism.  Prostate. 2003;  54 275-289
  CrossrefPubMedGoogle Scholar
• 15 Ji Q, Aoyama C, Nien Y-D et al.. Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling.  Cancer Res. 2004;  64 7610-7617
  CrossrefPubMedGoogle Scholar
• 16 Livak K J, Schmittgen T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)).  Methods. 2001;  25 402-408
  CrossrefPubMedGoogle Scholar
• 17 Glanemann C, Loos A, Gorret N et al.. Disparity between changes in mRNA abundance and enzyme activity in Corynebacterium glutamicum: implications for DNA microarray analysis.  Appl Microbiol Biotechnol. 2003;  61 61-68
  PubMedGoogle Scholar
• 18 Weinstein Y. 20alpha-hydroxysteroid dehydrogenase: a T lymphocyte-associated enzyme.  J Immunol. 1977;  119 1223-1229
  PubMedGoogle Scholar
• 19 Thomson A J, Telfer J F, Young A et al.. Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process.  Hum Reprod. 1999;  14 229-236
  CrossrefPubMedGoogle Scholar
• 20 Roh C R, Oh W J, Yoon B K, Lee J H. Up-regulation of matrix metalloproteinase-9 in human myometrium during labour: a cytokine-mediated process in uterine smooth muscle cells.  Mol Hum Reprod. 2000;  6 96-102
  CrossrefPubMedGoogle Scholar
• 21 Milewich L, Gomez-Sanchez C, Madden J D, MacDonald P C. Isolation and characterization of 5alpha-pregnane-3,20-dione and progesterone in pepipheral blood of pregnant women: measurement throughout pregnancy.  Gynecol Invest. 1975;  6 291-306
  PubMedGoogle Scholar
• 22 Lofgren M, Backstrom T, Joelsson I. Decrease in serum concentration of 5 alpha-pregnane-3,20-dione prior to spontaneous labor.  Acta Obstet Gynecol Scand. 1988;  67 467-470
  CrossrefPubMedGoogle Scholar
• 23 Perusquia M, Jasso-Kamel J. Influence of 5alpha- and 5beta-reduced progestins on the contractility of isolated human myometrium at term.  Life Sci. 2001;  68 2933-2944
  CrossrefPubMedGoogle Scholar
• 24 Lofgren M, Holst J, Backstrom T. Effects in vitro of progesterone and two 5 alpha-reduced progestins, 5 alpha-pregnane-3,20-dione and 5 alpha-pregnane-3 alpha-ol-20-one, on contracting human myometrium at term.  Acta Obstet Gynecol Scand. 1992;  71 28-33
  PubMedGoogle Scholar
• 25 Lonsdale D, Nylen K, McIntyre Burnham W. The anticonvulsant effects of progesterone and its metabolites on amygdala-kindled seizures in male rats.  Brain Res. 2006;  1101 110-116
  CrossrefPubMedGoogle Scholar
• 26 Kubli-Garfias C. Modulatory action of 5-reduced androgens and progestins on the excitability of CNS and smooth muscle.  J Steroid Biochem. 1987;  27 631-634
  CrossrefPubMedGoogle Scholar
• 27 Mahendroo M S, Porter A, Russell D W, Word R A. The parturition defect in steroid 5alpha-reductase type 1 knockout mice is due to impaired cervical ripening.  Mol Endocrinol. 1999;  13 981-992
  CrossrefPubMedGoogle Scholar
• 28 Sheehan P M, Rice G E, Moses E K, Brennecke S P. 5 Beta-dihydroprogesterone and steroid 5 beta-reductase decrease in association with human parturition at term.  Mol Hum Reprod. 2005;  11 495-501
  CrossrefPubMedGoogle Scholar

Richard H LeeM.D. 

Women's and Children's Hospital

1240 N. Mission Road, Room 5K-40, Los Angeles, CA 90033

Email: richarhl@usc.edu